Cargando…

Efficacy and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: a systematic literature review of randomized controlled trials

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a common liver disease that may progress into, in the absence of proper treatment, severe liver damage. While the optimal pharmacotherapy for NAFLD remains uncertain and the adherence to lifestyle interventions is challenging, the use of herba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Zuanji, Chen, Xianwen, Shi, Junnan, Hu, Hao, Xue, Yan, Ung, Carolina Oi Lam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802307/ https://www.ncbi.nlm.nih.gov/pubmed/33430929 http://dx.doi.org/10.1186/s13020-020-00422-x

Ejemplares similares

Applying regulatory science in traditional chinese medicines for improving public safety and facilitating innovation in China: a scoping review and regulatory implications
por: Liang, Zuanji, et al.
Publicado: (2021)

Efficacy and safety of traditional Chinese medicine for cancer-related fatigue: a systematic literature review of randomized controlled trials
por: Yang, Jingya, et al.
Publicado: (2023)

An evaluation of randomized controlled trials on nutraceuticals containing traditional Chinese medicines for diabetes management: a systematic review
por: Shi, Junnan, et al.
Publicado: (2019)

Systematic analysis of randomised controlled trials of Chinese herb medicine for non-alcoholic steatohepatitis (NASH): implications for future drug development and trial design
por: Chen, Xianwen, et al.
Publicado: (2023)

Advancing the Regulation of Traditional and Complementary Medicine Products: A Comparison of Five Regulatory Systems on Traditional Medicines with a Long History of Use
por: Liang, Zuanji, et al.
Publicado: (2021)

Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials
por: Li, Yuxiao, et al.
Publicado: (2023)

Application of implementation science framework to develop and adopt regulatory science in different national regulatory authorities
por: Shi, Junnan, et al.
Publicado: (2023)

Integrating traditional Chinese medicines into professional community pharmacy practice in China – Key stakeholder perspectives
por: Yao, Dongning, et al.
Publicado: (2020)

Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions
por: Lin, Annie Xianghong, et al.
Publicado: (2018)

Effectiveness and safety of traditional Chinese medicines for non-alcoholic fatty liver disease: Protocol for systematic review and meta-analysis
por: Qin, Manman, et al.
Publicado: (2020)

Integrating Real-World Evidence in the Regulatory Decision-Making Process: A Systematic Analysis of Experiences in the US, EU, and China Using a Logic Model
por: Li, Meng, et al.
Publicado: (2021)

Application of metabolomics in the diagnosis of non-alcoholic fatty liver disease and the treatment of traditional Chinese medicine
por: Shao, Mingmei, et al.
Publicado: (2022)

Protective effect of traditional Chinese medicine on non-alcoholic fatty liver disease and liver cancer by targeting ferroptosis
por: Wu, Qiongbo, et al.
Publicado: (2022)

“Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease
por: Guo, Kangxiao, et al.
Publicado: (2022)

Community pharmacists’ perceptions about pharmaceutical service of over-the-counter traditional Chinese medicine: a survey study in Harbin of China
por: Song, Menghuan, et al.
Publicado: (2017)

Internationalization of Traditional/Complementary Medicine products: market entry as medicine
por: Li, Jiatong, et al.
Publicado: (2018)

Towards consensus: defining and supporting a professional role for pharmacists associated with traditional and complementary medicines – a protocol of implementing an international e-survey
por: Harnett, Joanna E, et al.
Publicado: (2022)

Involving systems thinking and implementation science in pharmacists’ emerging role to facilitate the safe and appropriate use of traditional and complementary medicines
por: Harnett, Joanna E., et al.
Publicado: (2020)

Pharmacoeconomic evaluation of anti-obesity drugs for chronic weight management: a systematic review of literature
por: Xue, Yan, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Pathogenesis and Treatment in Traditional Chinese Medicine and Western Medicine
por: Shi, Tingting, et al.
Publicado: (2020)

Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine
por: Zhou, Zhijia, et al.
Publicado: (2022)

The Efficacy and Safety of Traditional Chinese Medicine (Jiang Zhi Granule) for Nonalcoholic Fatty Liver: A Multicenter, Randomized, Placebo-Controlled Study
por: Pan, Jielu, et al.
Publicado: (2013)

The prevalence, perceptions and behaviors associated with traditional/complementary medicine use by breastfeeding women living in Macau: a cross-sectional survey study
por: Zheng, Tingyun, et al.
Publicado: (2020)

Exploring the implementation of an outreach specialist program for nursing home residents in Macao: A multisite, qualitative study
por: Cen, Zhifeng, et al.
Publicado: (2022)

Literature Review of Traditional Chinese Medicine Herbs–Induced Liver Injury From an Oncological Perspective With RUCAM
por: Chow, Hei Ching, et al.
Publicado: (2019)

Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives
por: Dai, Xianmin, et al.
Publicado: (2021)

Etiology Exploration of Non-alcoholic Fatty Liver Disease From Traditional Chinese Medicine Constitution Perspective: A Cross-Sectional Study
por: Zhu, Ke, et al.
Publicado: (2021)

Community Pharmacists' Perceptions about Pharmaceutical Care of Traditional Medicine Products: A Questionnaire-Based Cross-Sectional Study in Guangzhou, China
por: Chen, Xi, et al.
Publicado: (2016)

Efficacy and safety assessment of traditional Chinese medicine for metabolic syndrome
por: Wu, Haoran, et al.
Publicado: (2020)

Progress in the mechanism of autophagy and traditional Chinese medicine herb involved in alcohol-related liver disease
por: Han, Wenwen, et al.
Publicado: (2023)

Key stakeholder perspectives on the barriers and solutions to pharmacy practice towards complementary medicines: an Australian experience
por: Ung, Carolina Oi Lam, et al.
Publicado: (2017)

Comparative analysis of disease modelling for health economic evaluations of systemic therapies in advanced hepatocellular carcinoma
por: Zou, Huimin, et al.
Publicado: (2023)

Traditional Chinese Medicine Induced Liver Injury
por: Teschke, Rolf
Publicado: (2014)

Efficacy and safety of semaglutide in non-alcoholic fatty liver disease
por: Zhu, Kai, et al.
Publicado: (2023)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Efficacy and safety of traditional Chinese medicine in the treatment of osteonecrosis of the femoral head
por: Ouyang, Wensi, et al.
Publicado: (2023)

Safety Concerns of Traditional Chinese Medicine Injections Used in Chinese Children
por: Tan, Liping, et al.
Publicado: (2019)

Regulatory effect of a Chinese herbal medicine formula on non-alcoholic fatty liver disease
por: Yang, Jia-Min, et al.
Publicado: (2019)

Impact of Up-Scheduling Medicines on Pharmacy Personnel, Using Codeine as an Example, with Possible Adaption to Complementary Medicines: A Scoping Review
por: Lee, Kristenbella AYR, et al.
Publicado: (2020)

Comparative efficacy of Chinese patent medicines for non-alcoholic fatty liver disease: A network meta-analysis
por: Zhang, Lihui, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fklr2d3rp0i1n4hg10fj009btf